Krishna Ella

Deccan Chronicle·14 Jan 2021

Bharat Biotech airlifts vaccine to 11 cities

Bharat Biotech , on Wednesday, became the second vaccine manufacturer in the country to airlift its Covid-19 vaccine to different states. The city-based company sent its Covaxin to 11 cities.

Telangana Today·14 Dec 2020

Belgium forging ties with Hyderabad

Belgium is strengthening its ties with Hyderabad, India’s largest life sciences hub, to help supply vaccines and drugs to global markets, particularly to the Europe region.

Telangana Today·11 Dec 2020

Foreign diplomats to visit vaccine facilities in Hyderabad

Foreign Ambassadors and High Commissioners from over 80 countries will be visiting the Bharat Biotech and Biological E manufacturing units in a few minutes to inspect the efforts that are under progress for a vaccine for Covid-19.

The Siasat Daily·9 Dec 2020

Over 60 foreign envoys to visit Hyderabad’s leading pharma companies

In the first such initiative, over 60 foreign envoys will be taken to Hyderabad-based leading biotech companies Bharat Biotech and Biological E on Wednesday in view of growing global interest in vaccine development program in India against coronavirus, official sources said on Tuesday.

The Hindu·16 Nov 2020

Coronavirus | Bharat Biotech’s COVID-19 vaccine Covaxin enters phase-3 trials

The COVID-19 vaccine, Covaxin, being developed by Bharat Biotech is now undergoing phase-3 trials, Krishna Ella, Chairman, and Managing Director, Bharat Biotech said on Monday. Speaking virtually at a program organized by the Indian School of Business, Mr.

The Hindu·1 Nov 2020

Coronavirus | Bharat Biotech plans to launch Covaxin in Q2 2021 upon approval from regulatory bodies

Bharat Biotech is planning to launch its vaccine for COVID-19 in the second quarter next year if it gets the requisite approvals from the Indian regulatory authorities, a top company official said.

The New Indian Express·26 Oct 2020

Bharat Biotech executive director: ‘Trying to raise manufacturing capacity above 500 million doses as soon as possible’

Bharat Biotech, which recently received approvals to conduct late-stage human trials of Covaxin — its Covid19 vaccine candidate — has committed “significant” investment towards expanding its ability to make the vaccine, according to the company’s executive director, Sai Prasad.